Skip to main content


Figure 1 | BMC Ophthalmology

Figure 1

From: Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease

Figure 1

Funduspictures taken from patient 4. Top: Funduscopic findings before ranibizumab injections show plus disease with tortuous, dilated blood vessels. On the right, the ridge with neovascularisations can be appreciated under sclera indentation. Middle: One week post-injection plus disease has almost completely disappeared. Bottom: Six month post treatment, retinal vascularisation is complete without recurrence of ROP.

Back to article page